JK

Jitendra Kumar

Director Director DIN 06905917
DIN 06905917 First appointment Aug 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Jitendra Kumar

Data last updated:

Jitendra Kumar was a Director at Meckley Life Sciences Private Limited (2014–2017) and Director at Elyse Healthcare Private Limited (from 2019). The companies operate in Pharma.

DIN 06905917
Primary Designation Director
Industry Pharma
First Appointment 25 Aug 2014
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Aug 20142014₹2.83 Cr (FY 2025)Active
Elyse Healthcare Private Limited U74999MH2019PTC333346
Director20 Nov 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Elyse Healthcare Private Limited
Meckley Life Sciences Private Limited
Premium access

Shareholding and investment profile for Jitendra Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendra Kumar

Jitendra Kumar was first appointed on 25 Aug 2014 as Director at Meckley Life Sciences Private Limited. The most recent appointment on record is 20 Nov 2019 at Elyse Healthcare Private Limited.

Jitendra Kumar held 2 earlier board appointments: Meckley Life Sciences Private Limited (Director, 25 Aug 2014 to 14 Dec 2017); Elyse Healthcare Private Limited (Director, from 20 Nov 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available